Safety and Repeatability of Bronchial Challenge With Grass-pollen
NCT00507039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2011-10-12
Summary
The study is meant to establish a one-step challenge with grass-pollen in patients sensitized for grass-pollen. Therefore the investigators compare a multi-step challenge with grass-pollen with an one-step challenge in order to survey the repeatability and safety.
Conditions
- Allergic Asthma
Interventions
- PROCEDURE
-
inhalative grass-pollen provocation
Subjects undergo allergen challenges with incremental doses of grass pollen allergen. In subjects, who develop a fall in FEV1 of more than 20%, this will be followed by two single-step challenges.
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Principal Investigators
-
Stefan Zielen, M.D., Ph.D · Goethe University, Department of Pulmonology
Eligibility
- Min Age
- 12 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2008-09-30
- Completion
- 2009-12-31
Countries
- Germany
Study Locations
More Related Trials
-
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
NCT01385371 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study of PQ Grass 27600 SU
NCT04687059 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis
NCT00263601 ·Status: COMPLETED ·Phase: PHASE3
-
Repeat Nasal Allergen Challenge
NCT00290368 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
NCT00309036 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459 ·Status: COMPLETED ·Phase: PHASE3
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
NCT00567346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cellulose Powder Against Grass Pollen Allergic Rhinitis
NCT03039816 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients
NCT00857779 ·Status: COMPLETED ·Phase: PHASE2
-
Revaccination With Pollinex® Quattro
NCT02579720 ·Status: COMPLETED
-
The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit
NCT00209365 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
NCT00293904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
NCT00841256 ·Status: COMPLETED ·Phase: PHASE3
-
Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
NCT00135642 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of the ALK Grass Tablet in Subjects With Hayfever
NCT00227279 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)
NCT01953471 ·Status: COMPLETED
-
Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)
NCT00562159 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
NCT00812799 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis
NCT04700852 ·Status: UNKNOWN ·Phase: NA
-
Nasya in Allergic Rhinitis
NCT01503957 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
NCT04389034 ·Status: COMPLETED
-
Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber
NCT01222299 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy
NCT01555736 ·Status: COMPLETED ·Phase: PHASE4